← Back
▼ SELL 10b5-1 Plan

$ Value

$122K

Shares

3,472

Price

$35

Filed

Apr 6

Insider

Name

Hopper Jonathan Mark

Title

Chief Medical Officer

CIK

0001626325

Roles

Officer

Transaction Details

Transaction Date

2026-04-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

75,556

Footnotes

These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). | The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025. | These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

Filing Info

Accession No.

0001140361-26-013334

Form Type

4

Issuer CIK

0000887359

Hopper Jonathan Mark's History

Date Ticker Type Value
2026-04-02 VCEL M $38K
2026-04-02 VCEL $122K
2026-04-02 VCEL M $0
2026-02-24 VCEL M
2026-02-24 VCEL M $0
2026-02-24 VCEL F $51K
2026-02-24 VCEL M
2026-02-24 VCEL M $0
2026-02-24 VCEL F $24K
2026-02-24 VCEL M

Other Insiders at VCEL (90d)

Insider Bought Sold Last
MCLAUGHLIN KEVIN F $243K 2026-02-11
Colangelo Dominick
President and CEO
2026-02-24
Rubino Alan L 2026-03-25
Hagen Heidi $486K 2026-03-23
Hopper Jonathan Mark
Chief Medical Officer
2026-04-02
Halpin Michael
Chief Operating Officer
$364K 2026-03-02
Flynn Sean C.
Chief Legal Officer
$754K 2026-03-02
Mara Joseph Anthony Jr
Chief Financial Officer
2026-02-24
SIEGAL JONATHAN
Principal Accounting Officer
2026-02-24